Apr 14, 2010 | Laboratory Management and Operations, Laboratory Pathology, Managed Care Contracts & Payer Reimbursement
In the long term, quality measures should elevate recognition of the value of clinical pathology testing Healthcare quality measures continue to increase, both in numbers and in sophistication. These quality measures offer consumers, insurers, employers, and government health agencies some information about the relative value of clinical services. But the holy grail of quality measures—outcomes data and cost data that adequately reflect patient complexity and environment—is still elusive, say...
